��������

Eugene brings extensive expertise in cell assay miniaturization. His career in academy and industry was driven by the desire to explain heterogeneity of cellular behavior by analyzing one cell at a time. As a professor of Pediatrics at University of California, San Diego, his lab was studying vascular remodeling using microfluidic devices and animal models. In 2015, Dr. Tkachenko established MuWells, a microfluidic foundry, and was its CEO until the company merged with Celldom in 2022. Under his leadership, MuWells has completed more than 2000 custom microfluidic chip projects for over 70 customers in biotech, academy, and pharma; developed a CytoSoft® product line which was acquired by Advanced Biomatrix; and established patent-protected miniaturized cell assay platform which is now being commercialized by Celldom. Dr. Tkachenko has authored 24 articles in prestigious peer-review journals and 4 patents.